ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,064.20
0.91%
Dow Jones
38,225.66
0.85%
US Dollar vs MXN
16.9651
-0.04%
Brent Oil
83.955
0.39%
Bitcoin
59,267.85
0.25%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Cassava Sciences Inc (SAVA)

  7. Cassava Sciences Inc (SAVA) Noticias

SAVA Cassava Sciences Inc

21.96
-0.18 (-0.81%)
02 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Cassava Sciences Inc SAVA NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
-0.18 -0.81% 21.96 18:58:39
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
22.20 21.89 22.25 22.06 22.14
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
01/5/202408:10GLOBETomorrow is Last Day to Trade SAVAW Warrants on NASDAQ
15/4/202408:20GLOBERedemption Date Announced for Warrants
25/3/202408:13GLOBECassava Sciences Announces Completion of an Interim Safety..
04/3/202408:15GLOBECassava Sciences Announces Virtual Presentation at the..
28/2/202415:01EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
28/2/202408:22EDGAR2Form 8-K - Current report
28/2/202408:14GLOBECassava Sciences Reports Full-year 2023 Financial Results..
07/2/202408:20EDGAR2Form 8-K - Current report
07/2/202408:08GLOBENo Decline in Cognition Scores in Patients with Mild..
01/2/202415:00EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
26/1/202415:23EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
05/1/202408:12GLOBECassava Sciences Completes Dividend Distribution of Warrants..
03/1/202415:24EDGAR2Form CERT - Certification by an exchange approving..
03/1/202415:22EDGAR2Form 424B2 - Prospectus [Rule 424(b)(2)]
03/1/202415:18EDGAR2Form 8-A12B - Registration of securities [Section 12(b)]
03/1/202408:10EDGAR2Form 8-K - Current report
02/1/202408:10EDGAR2Form 8-A12G - Registration of securities [Section 12(g)]
12/12/202308:19EDGAR2Form 8-K - Current report
12/12/202308:13GLOBECassava Sciences Announces Dividend Distribution of Warrants..
11/12/202315:18EDGAR2Form 8-K - Current report
08/12/202316:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/12/202315:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/12/202315:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/12/202315:01GLOBECassava Sciences Appoints Three New Members to its Board of..
07/11/202308:19EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202308:08EDGAR2Form 8-K - Current report
07/11/202308:01GLOBECassava Sciences Reports Third Quarter 2023 Financial and..
06/11/202308:15GLOBECassava Sciences Completes Enrollment for Pivotal Phase 3..
25/10/202308:15GLOBEMRI Data Suggest Simufilam is Not Associated with..
13/10/202308:06IHMARKETNEWSFriday’s Wall Street Highlights: Dollar General, Microsoft,..
12/10/202322:43GLOBEStatement by Cassava Sciences Regarding an Internal CUNY..
05/10/202308:15GLOBECassava Sciences to Present at the Jefferies Biotech..
04/10/202317:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202317:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202317:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202317:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/10/202308:00GLOBECassava Sciences Completes Patient Enrollment for Pivotal..
18/9/202308:15GLOBECassava Sciences Announces Positive Interim Safety Review of..
13/9/202315:17EDGAR2Form 8-K - Current report
11/9/202308:10GLOBECassava Sciences Announces Science Publication That Confirms..
06/9/202308:15GLOBECassava Sciences Invited to Present in Four Upcoming..
24/8/202315:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/8/202315:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/8/202315:35EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/8/202308:12EDGAR2Form 8-K - Current report
03/8/202308:07GLOBECassava Sciences Reports Q2 2023 Financial Results and..
05/7/202308:25EDGAR2Form 8-K - Current report
05/7/202308:15GLOBEOral Simufilam Slowed Cognitive Decline in a Randomized..
27/6/202308:15GLOBENew Research Shows Simufilam Suppresses Overactive mTOR
12/6/202308:15GLOBENew Publication Highlights Basic Science Supporting..

Su Consulta Reciente

NASDAQ
SAVA
Cassava Sciences
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados